Studying a ribosome variant within Bacillus subtilis called "L22," the researchers ... the way for another drug-free approach to managing infections. The advancement was proven to reduce the ...

subtilis from Treacy produced an “antibiotic substance.” In 1948, the Food and Drug Administration approved an antibiotic medication based on the discovery—bacitracin, after “Bacillus ...

It is produced by Bacillus subtilis (Gehrig & Warshaw ... Like neomycin, bacitracin fights infections of the skin, ear, and eyes. It is active against gram-positive bacteria and spirochetes.